ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.855,15
0,41%
S&P 500
5.996,66
1,00%
US Dollar vs BRL
6,033
0,03%
Bitcoin
102.209,52
0,18%
Brent Oil
79,405
0,23%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. CareDx Inc (CDNA)

  7. CareDx Inc (CDNA) Notícias

CDNA

CareDx (CDNA)

CareDx Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDNA
DataHoraFonteTítuloCódigoCompanhia
13/01/202509:00Business WireCareDx Announces Preliminary Fourth Quarter and Full Year 2024 ResultsNASDAQ:CDNACareDx Inc
10/01/202523:46Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDNACareDx Inc
08/01/202518:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDNACareDx Inc
08/01/202518:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDNACareDx Inc
18/12/202409:05Business WireCareDx to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CDNACareDx Inc
11/12/202409:00Business WireCareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell TherapyNASDAQ:CDNACareDx Inc
11/12/202409:00PR Newswire (US)TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell TherapyNASDAQ:CDNACareDx Inc
04/12/202418:42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CDNACareDx Inc
18/11/202409:00Business WireGestion mondiale d’actifs CI annonce un nombre de fusions de fonds communs de placement et de FNB et une modification de la cote de risqueNASDAQ:CDNACareDx Inc
14/11/202419:13Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDNACareDx Inc
12/11/202409:05Business WireCareDx to Participate in Upcoming Investor ConferencesNASDAQ:CDNACareDx Inc
04/11/202418:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDNACareDx Inc
04/11/202418:05Business WireCareDx Reports Third Quarter 2024 Results and Raises Revenue GuidanceNASDAQ:CDNACareDx Inc
23/10/202408:00Business WireCareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C TechnologyNASDAQ:CDNACareDx Inc
21/10/202408:00Business WireCareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics MeetingNASDAQ:CDNACareDx Inc
15/10/202407:00Business WireCareDx Reports Preliminary Financial Results for Third Quarter 2024NASDAQ:CDNACareDx Inc
11/10/202417:30Business WireCareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CDNACareDx Inc
09/10/202408:05Business WireCareDx Appoints Jing Huang Chief Data and AI OfficerNASDAQ:CDNACareDx Inc
08/10/202417:05Business WireCareDx to Host Investor Day on October 15, 2024NASDAQ:CDNACareDx Inc
08/10/202407:05Business WireCareDx Announces Closure of DOJ Investigation with No Finding of WrongdoingNASDAQ:CDNACareDx Inc
16/09/202417:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CDNACareDx Inc
13/09/202421:33Business WireCareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CDNACareDx Inc
13/09/202418:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CDNACareDx Inc
12/09/202408:01Business WireCareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial OfficerNASDAQ:CDNACareDx Inc
16/08/202415:10Business WireCareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap TestingNASDAQ:CDNACareDx Inc
31/07/202417:05Business WireCareDx Reports Second Quarter 2024 Results and Increases Revenue GuidanceNASDAQ:CDNACareDx Inc
16/07/202408:05Business WireCareDx to Report Second Quarter 2024 Financial ResultsNASDAQ:CDNACareDx Inc
03/06/202408:05Business WireLandmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable PatientsNASDAQ:CDNACareDx Inc
30/05/202408:05Business WireAI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant CongressNASDAQ:CDNACareDx Inc
29/05/202409:05Business WireCareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is IrrelevantNASDAQ:CDNACareDx Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDNA

Seu Histórico Recente

BOV
IAAG12
Inter Amerra Fiagro Imob...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados